Global Edition news
An illustrated graphic of how the Nerivio Migra device works. Source: Theranica
May 28, 2019
Theranica, an Israel-based biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, announced on May 28 that the U.S. Food and Drug Administration (FDA) granted a De Novo request for its smartphone-controlled electroceutical, Nerivio Migra, utilising Remote Electrical Neuromodulation for the acute treatment of migraine.
May 28, 2019
Microsoft recently detailed two partnerships with pediatric health research groups that have yielded tools and insights for clinicians tackling prevalent conditions.
The first, with Seattle Children’s Research Institute, saw the two organizations teaming up on a data-driven partnership aiming to identify predictors and risk factors for sudden infant death syndrome (SIDS). By collecting public...
Babyl activation event in Rwanda. As part of the service communities have access to virtual consultations with doctors and experts, as well as monitoring and diagnostic tools. Photo credit: Babyl Rwanda
May 24, 2019
With billions of dollars pouring into the biggest tech hubs in the world like Silicon Valley, New York and Beijing, it can be easy to forget about other health technologies under development in regions without the same resources.
However, digital health has already started changing care around the world, especially in developing regions, making care more accessible and cost effective. In...
May 23, 2019
A low-density sprawl of 420,000 people that is known as “the bush capital”, Canberra would appear to be an unlikely digital transformation hub. But above its leafy boulevards, national institutions and mobs of kangaroos, a fleet of mini planes will soon be zipping around carrying painkillers, lattes, gelato and golf balls.
Wing announced in April that it had received Civil Aviation Safety...
May 21, 2019
Public health departments are now getting a little bit of help from Facebook to map out where diseases are spreading worldwide. The social media giant recently launched three new maps aimed at helping public health officials tackle the problem of pinpointing where diseases are present and spreading. The new additions include high-resolution population density maps with demographic estimates,...
May 21, 2019
This morning, artificial-intelligence-enabled monitoring and decision support platform Biofourmis announced a $35 million Series B raise. The round was led by Sequoia India and MassMutual Ventures with participation from EDBI, Jianke and existing investors Openspace Ventures, Aviva Ventures and SGInnovate.
The funding announcement coincided with the news that the Singaporean company will be...
May 20, 2019
MyHeritage, an Israeli company that has been doing ancestry-related genetic testing since 2016, has announced a new product that brings the company into the health-focused consumer DNA testing space alongside the likes of 23andMe.
MyHeritage DNA Health+Ancestry is a single test that includes a wide-range of genetic aptitudes for possible health conditions: specifically, the company will offer 11...
May 17, 2019
Listening has always been a critical component to medicine. Increasingly the healthcare world is seeing the value in listening to patients’ stories and helping these narratives drive hospital transformation.
“Patient stories provide rich, qualitative data, and context to the critical texture, which is how are we doing in delivering great patient care and a great patient experience,” Lee Chen Ee...
May 16, 2019
Help from above. The Department of Justice has taken the side of tech-enabled insurer Oscar Health in a federal antitrust suit it filed in November of last year against Florida Blue, Crain’s New York Business reports. While Oscar’s motion for a temporary injunction was rejected by a federal judge back in February, the DOJ filed a statement in April arguing that Florida Blue had incorrectly...
May 16, 2019
About the author: Joe Slavinsky leads business development efforts with pharmaceutical, biotechnology and medical technology companies in his VP position at Propeller Health. A former epidemiologist, he worked at a hedge fund (Citadel) and an investment bank (Thomas Weisel Partners) as an equity research analyst covering small/mid-cap biotechnology companies. Joe joined Propeller from Gilead...